Tiggs, Kyra |
MRN: 161023 | Room: 525 | DOB: 3/21/1971 | Age: 54 | Gender: Female | Allergies: Penicillin (rash) |
Setting | Adult Medicine Unit | ||
Scenario | In the emergency room, KT is diagnosed with atrial fibrillation and the medical team decides to pursue rate control. After receiving three doses of IV metoprolol tartrate, the patient reports improvement in her symptoms, denying further episodes of dizziness, palpitations, and shortness of breath. Repeat ECG demonstrates irregularly irregular rhythm and telemetry shows that KT’s heart rate is currently 80 bpm and blood pressure is 142/80 mm Hg. KT is admitted to the general medicine floor at midnight for further monitoring. Her HR remains controlled at 76 to 80 bpm and her blood pressure is stable at 142/80 mm Hg. Given resolution of symptoms, the medicine team decides to continue rate control therapy and transition KT back to oral metoprolol succinate. The physician is unsure what dose of metoprolol succinate to order and if anticoagulation is warranted or not, thus he consults you for rate control and anticoagulation recommendations. The physician would also appreciate other suggestions you have regarding this patient’s care. |
||
Admission note taken on 10/18/25 | |||
CC | "My heart is beating very fast, I can’t breathe, and I have been tired and dizzy the past two days." | ||
HPI | KT presented to the emergency room complaining of palpitations, shortness of breath, dizziness, and fatigue for the past two days. She endorses prior episodes that lasted a few days in the past but never sought further evaluation because she attributed dialysis to be the cause of her symptoms. KT reports her last dialysis session was October 6th and states she is 100% adherent to her dialysis schedule. | ||
PMH |
|
||
Social History |
|
Family History |
|
Vaccine History |
|
Surgical History |
|
Physical Exam |
|
Test Name | 10/19/25 | 10/18/25 | Range |
Sodium (Na+) | 137 | 139 | 136-145 mEq/L |
Potassium (K+) | 4.8 | 4.8 | 3.5-5 mEq/L |
Chloride (Cl-) | 98 | 95 | 98-106 mEq/L |
Bicarbonate (HCO3-) | 28 | 27 | 23-28 mEq/L |
Urea nitrogen (BUN) | 29 | 29 | 8-20 mg/dL |
Creatinine | 8.14 | 8.4 | 0.5-1.3 mg/dL |
Glucose | 210 | 212 | 70-115 mg/dL |
Hemoglobin A1c | 8.6 | 5.3-7.5 % | |
Calcium,Total | 8.5 | 8.6 | 8.6-10.2 mg/dL |
Phosphate | 3.6 | 3.7 | 3-4.5 mg/dL |
Magnesium | 2.0 | 2.1 | 1.6-2.6 mEq/L |
Protein, total | 5.2 | 5 | 5.5-9 g/dL |
Albumin | 3.1 | 3 | 3.5-5.5 g/dL |
Aminotransferase,aspartate (AST) | 20 | 20 | 10-40 units/L |
Aminotransferase,alanine (ALT) | 18 | 18 | 10-40 units/L |
Lactic dehydrogenase (LDH) | 151 | 155 | 80-225 units/L |
Alkaline phosphatase | 74 | 74 | 30-120 units/L |
Bilirubin, Total | 0.7 | 0.7 | 0.3-1 mg/dL |
Leukocytes (WBC) | 6.8 | 6.8 | 4.5-11 x103/mcL |
Red blood cells (RBC), Female | 4.9 | 4.8 | 4.3-5.7 x108/mcL |
Hemoglobin, Female | 9.8 | 10 | 12-16 g/dL |
Hematocrit, Female | 30 | 30.6 | 37-47 % |
Mean corpuscular hemoglobin (MCH) | 31 | 30 | 27-33 picogram |
Mean corpuscular volume (MCV) | 82 | 81 | 76-100 mcm3 |
Platelets | 212 | 205 | 150-450 x103/mcL |
International normalized ratio (INR) | 1 | 1 | 0.8-1.2 |
Prothrombin time (PT) | 11.4 | 11.1 | 9.5-11.3 sec |
Partial thromboplastin time,activated (aPTT) | 33 | 33 | 25-35 sec |
Additional Labs: |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cultures: | None | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Imaging Studies: |
|
|
Medication History |
|
Patient Name: Tiggs, Kyra Date of Birth: 3/21/1971 Room#: 525 |
Allergies: |
Immunization History: |
Community Rx Info: Rx Insurance: |
Social History: |
|
Additional Notes: |
STRENGTH DF |
ROUTE FREQ |
DOSE (date/time) |
EFFECTS |
ACTION |
REASON |
|||
---|---|---|---|---|---|---|---|---|
Action Key: C = Continue, D = Discontinue*, H = Hold*, M = Modify* *must provide reason |
Medication | 10/19/25 | 10/18/25 |
Sevelamer 1,600 mg PO TID | 09:10 14:12 19:21 | |
Lisinopril 2.5 mg PO QD | 09:57 | |
Insulin Glargine 10 units SC HS | 21:47 | |
Insulin Aspart sliding scale SC TID | 06:26 11:20 16:33 | |
Metoprolol tartrate 5 mg IV push STAT x3 doses | 22:38 22:57 22:24 |
Hospital Medications | ||||||
Medication | Instructions | Comments | Continue | Modify | Discontinue | New Rx sent |
Previous Home Medications | ||||||
Medication | Instructions | Comments | Continue | Modify | Discontinue | New Rx sent |
Patient Name: | ||
Admission Date: | Discharge Date: | Service: |
Principle Diagnosis on Admission: | ||
Secondary Diagnosis: | ||
Allergies: |
Medications ADDED this visit: (begin taking these) |
Medications CHANGED this visit: (modify what you were taking) |
Medications STOPPED this visit: (stop taking these) |
Final Discharge Medication List | |||||
Medication/Route/Dosage/Frequency/Duration | Comments | Morning | Afternoon | Evening | Bedtime |
As Needed Medications | |||||
Patient Name: Tiggs, Kyra | Date of Birth: 3/21/1971 | Room: 525 |
Medication (name/strength) | Dose | Route | Frequency | Notes |